Skip to main content
Journal of Virology logoLink to Journal of Virology
. 1996 Apr;70(4):2420–2430. doi: 10.1128/jvi.70.4.2420-2430.1996

E5 oncoprotein transmembrane mutants dissociate fibroblast transforming activity from 16-kilodalton protein binding and platelet-derived growth factor receptor binding and phosphorylation.

J Sparkowski 1, M Mense 1, J Anders 1, R Schlegel 1
PMCID: PMC190085  PMID: 8642670

Abstract

The E5 oncoprotein of bovine papillomavirus type 1 is a 44-amino-acid, hydrophobic polypeptide which localizes predominantly in Golgi membranes and appears to transform cells through the activation of tyrosine kinase growth factor receptors. In fibroblasts, E5 interacts with both the 16-kilodalton vacuolar ATPase subunit and the platelet-derived growth factor receptor (PDGF-R) via its hydrophobic transmembrane domain and induces autophosphorylation of the receptor. To further analyze the correlation between E5 biological activity and its ability to bind these cellular proteins, a series of nine E5 transmembrane mutants was evaluated. In 32D mouse hematopoietic cells, there was an incomplete correlation between the abilities of the E5 mutant proteins to associate the PDGF-R and to transform cells. However, all transforming E5 mutant proteins induced PDGF-R tyrosine phosphorylation. In NIH 3T3 and C127 mouse fibroblasts, both transforming and nontransforming E5 mutant proteins were defective for PDGF-R binding. In addition, while most of the transforming E5 proteins induced PDGF-R phosphorylation, one hypertransforming mutant (serine 17) neither bound nor induced receptor autophosphorylation. These findings support the hypothesis that the transformation of fibroblasts by E5 transmembrane mutants can involve alternative cellular targets or potentially independent activities of the E5 protein. In addition, these results underscore the critical role of the transmembrane domain in mediating E5 biological activities.

Full Text

The Full Text of this article is available as a PDF (710.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andresson T., Sparkowski J., Goldstein D. J., Schlegel R. Vacuolar H(+)-ATPase mutants transform cells and define a binding site for the papillomavirus E5 oncoprotein. J Biol Chem. 1995 Mar 24;270(12):6830–6837. doi: 10.1074/jbc.270.12.6830. [DOI] [PubMed] [Google Scholar]
  2. Band V., Zajchowski D., Kulesa V., Sager R. Human papilloma virus DNAs immortalize normal human mammary epithelial cells and reduce their growth factor requirements. Proc Natl Acad Sci U S A. 1990 Jan;87(1):463–467. doi: 10.1073/pnas.87.1.463. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohen B. D., Goldstein D. J., Rutledge L., Vass W. C., Lowy D. R., Schlegel R., Schiller J. T. Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain. J Virol. 1993 Sep;67(9):5303–5311. doi: 10.1128/jvi.67.9.5303-5311.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cohen B. D., Lowy D. R., Schiller J. T. The conserved C-terminal domain of the bovine papillomavirus E5 oncoprotein can associate with an alpha-adaptin-like molecule: a possible link between growth factor receptors and viral transformation. Mol Cell Biol. 1993 Oct;13(10):6462–6468. doi: 10.1128/mcb.13.10.6462. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Di Fiore P. P., Pierce J. H., Kraus M. H., Segatto O., King C. R., Aaronson S. A. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells. Science. 1987 Jul 10;237(4811):178–182. doi: 10.1126/science.2885917. [DOI] [PubMed] [Google Scholar]
  6. DiMaio D., Guralski D., Schiller J. T. Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. Proc Natl Acad Sci U S A. 1986 Mar;83(6):1797–1801. doi: 10.1073/pnas.83.6.1797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Drummond-Barbosa D. A., Vaillancourt R. R., Kazlauskas A., DiMaio D. Ligand-independent activation of the platelet-derived growth factor beta receptor: requirements for bovine papillomavirus E5-induced mitogenic signaling. Mol Cell Biol. 1995 May;15(5):2570–2581. doi: 10.1128/mcb.15.5.2570. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Dvoretzky I., Shober R., Chattopadhyay S. K., Lowy D. R. A quantitative in vitro focus assay for bovine papilloma virus. Virology. 1980 Jun;103(2):369–375. doi: 10.1016/0042-6822(80)90195-6. [DOI] [PubMed] [Google Scholar]
  9. Dvoretzky I., Shober R., Chattopadhyay S. K., Lowy D. R. A quantitative in vitro focus assay for bovine papilloma virus. Virology. 1980 Jun;103(2):369–375. doi: 10.1016/0042-6822(80)90195-6. [DOI] [PubMed] [Google Scholar]
  10. Goldstein D. J., Kulke R., Dimaio D., Schlegel R. A glutamine residue in the membrane-associating domain of the bovine papillomavirus type 1 E5 oncoprotein mediates its binding to a transmembrane component of the vacuolar H(+)-ATPase. J Virol. 1992 Jan;66(1):405–413. doi: 10.1128/jvi.66.1.405-413.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Goldstein D. J., Li W., Wang L. M., Heidaran M. A., Aaronson S., Shinn R., Schlegel R., Pierce J. H. The bovine papillomavirus type 1 E5 transforming protein specifically binds and activates the beta-type receptor for the platelet-derived growth factor but not other related tyrosine kinase-containing receptors to induce cellular transformation. J Virol. 1994 Jul;68(7):4432–4441. doi: 10.1128/jvi.68.7.4432-4441.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Goldstein D. J., Schlegel R. The E5 oncoprotein of bovine papillomavirus binds to a 16 kd cellular protein. EMBO J. 1990 Jan;9(1):137–145. doi: 10.1002/j.1460-2075.1990.tb08089.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Greenberger J. S., Davisson P. B., Gans P. J., Moloney W. C. In vitro induction of continuous acute promyelocytic leukemia cell lines by Friend or Abelson murine leukemia virus. Blood. 1979 May;53(5):987–1001. [PubMed] [Google Scholar]
  14. Greenberger J. S., Sakakeeny M. A., Humphries R. K., Eaves C. J., Eckner R. J. Demonstration of permanent factor-dependent multipotential (erythroid/neutrophil/basophil) hematopoietic progenitor cell lines. Proc Natl Acad Sci U S A. 1983 May;80(10):2931–2935. doi: 10.1073/pnas.80.10.2931. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Groff D. E., Lancaster W. D. Genetic analysis of the 3' early region transformation and replication functions of bovine papillomavirus type 1. Virology. 1986 Apr 15;150(1):221–230. doi: 10.1016/0042-6822(86)90281-3. [DOI] [PubMed] [Google Scholar]
  16. Horwitz B. H., Burkhardt A. L., Schlegel R., DiMaio D. 44-amino-acid E5 transforming protein of bovine papillomavirus requires a hydrophobic core and specific carboxyl-terminal amino acids. Mol Cell Biol. 1988 Oct;8(10):4071–4078. doi: 10.1128/mcb.8.10.4071. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Klymkowsky M. W., Shook D. R., Maynell L. A. Evidence that the deep keratin filament systems of the Xenopus embryo act to ensure normal gastrulation. Proc Natl Acad Sci U S A. 1992 Sep 15;89(18):8736–8740. doi: 10.1073/pnas.89.18.8736. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Lancaster W. D., Olson C. Animal papillomaviruses. Microbiol Rev. 1982 Jun;46(2):191–207. doi: 10.1128/mr.46.2.191-207.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Lee B. A., Donoghue D. J. Membrane-anchored form of v-sis/PDGF-B induces mitogenesis without detectable PDGF receptor autophosphorylation. J Cell Biol. 1991 Apr;113(2):361–370. doi: 10.1083/jcb.113.2.361. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Martin P., Vass W. C., Schiller J. T., Lowy D. R., Velu T. J. The bovine papillomavirus E5 transforming protein can stimulate the transforming activity of EGF and CSF-1 receptors. Cell. 1989 Oct 6;59(1):21–32. doi: 10.1016/0092-8674(89)90866-0. [DOI] [PubMed] [Google Scholar]
  21. Mincheva A., Gissmann L., zur Hausen H. Chromosomal integration sites of human papillomavirus DNA in three cervical cancer cell lines mapped by in situ hybridization. Med Microbiol Immunol. 1987;176(5):245–256. doi: 10.1007/BF00190531. [DOI] [PubMed] [Google Scholar]
  22. Nilson L. A., DiMaio D. Platelet-derived growth factor receptor can mediate tumorigenic transformation by the bovine papillomavirus E5 protein. Mol Cell Biol. 1993 Jul;13(7):4137–4145. doi: 10.1128/mcb.13.7.4137. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Nilson L. A., Gottlieb R. L., Polack G. W., DiMaio D. Mutational analysis of the interaction between the bovine papillomavirus E5 transforming protein and the endogenous beta receptor for platelet-derived growth factor in mouse C127 cells. J Virol. 1995 Sep;69(9):5869–5874. doi: 10.1128/jvi.69.9.5869-5874.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Petti L., DiMaio D. Specific interaction between the bovine papillomavirus E5 transforming protein and the beta receptor for platelet-derived growth factor in stably transformed and acutely transfected cells. J Virol. 1994 Jun;68(6):3582–3592. doi: 10.1128/jvi.68.6.3582-3592.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Petti L., Nilson L. A., DiMaio D. Activation of the platelet-derived growth factor receptor by the bovine papillomavirus E5 transforming protein. EMBO J. 1991 Apr;10(4):845–855. doi: 10.1002/j.1460-2075.1991.tb08017.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Pierce J. H., Ruggiero M., Fleming T. P., Di Fiore P. P., Greenberger J. S., Varticovski L., Schlessinger J., Rovera G., Aaronson S. A. Signal transduction through the EGF receptor transfected in IL-3-dependent hematopoietic cells. Science. 1988 Feb 5;239(4840):628–631. doi: 10.1126/science.3257584. [DOI] [PubMed] [Google Scholar]
  27. Riese D. J., 2nd, DiMaio D. An intact PDGF signaling pathway is required for efficient growth transformation of mouse C127 cells by the bovine papillomavirus E5 protein. Oncogene. 1995 Apr 6;10(7):1431–1439. [PubMed] [Google Scholar]
  28. Schiller J. T., Vass W. C., Vousden K. H., Lowy D. R. E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J Virol. 1986 Jan;57(1):1–6. doi: 10.1128/jvi.57.1.1-6.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schlegel R., Wade-Glass M., Rabson M. S., Yang Y. C. The E5 transforming gene of bovine papillomavirus encodes a small, hydrophobic polypeptide. Science. 1986 Jul 25;233(4762):464–467. doi: 10.1126/science.3014660. [DOI] [PubMed] [Google Scholar]
  30. Sparkowski J., Anders J., Schlegel R. E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells. EMBO J. 1995 Jul 3;14(13):3055–3063. doi: 10.1002/j.1460-2075.1995.tb07308.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Sparkowski J., Anders J., Schlegel R. Mutation of the bovine papillomavirus E5 oncoprotein at amino acid 17 generates both high- and low-transforming variants. J Virol. 1994 Sep;68(9):6120–6123. doi: 10.1128/jvi.68.9.6120-6123.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Staebler A., Pierce J. H., Brazinski S., Heidaran M. A., Li W., Schlegel R., Goldstein D. J. Mutational analysis of the beta-type platelet-derived growth factor receptor defines the site of interaction with the bovine papillomavirus type 1 E5 transforming protein. J Virol. 1995 Oct;69(10):6507–6517. doi: 10.1128/jvi.69.10.6507-6517.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tada A., Sekine H., Yamamoto T., Fuse A., Simizu B. Characterization of bovine papillomavirus type 1-transformed clones which show distinct transformed phenotypes. J Gen Virol. 1989 Jun;70(Pt 6):1593–1599. doi: 10.1099/0022-1317-70-6-1593. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Virology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES